30.01.22|Yafit OvadiaBELKIN Vision is using an automated laser procedure to tackle glaucoma, a disease that can lead to irreversible blindness
21.07.20|Hagar Ravet The company is in the midst of clinical testing of its one-second glaucoma treatment with the product expected to enter the market in two years
21.11.17|Lilach BaumerThe Chengdu Kanghong Pharma Group will buy Tel Aviv-based IOPtima in four stages, the latter announced Tuesday through its parent company listed on the Tel Aviv Stock Exchange